Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Syed Shahzad Hasan, Chia Siang Kow, Louise E Curley, Darrin L Baines & Zaheer-Ud-Din Babar. (2018) Economic evaluation of prescribing conventional and newer oral anticoagulants in older adults. Expert Review of Pharmacoeconomics & Outcomes Research 18:4, pages 371-377.
Read now
Read now
Articles from other publishers (12)
Rajeswari Aghoram, S. Mathan Kumar, Subramania Raju Rajasulochana, Sitanshu Sekhar Kar & Rakesh Aggarwal. (2022) Cost-Utility Analysis of Dabigatran and Warfarin for Stroke Prevention Among Patients With Nonvalvular Atrial Fibrillation in India. Value in Health Regional Issues 31, pages 119-126.
Crossref
Crossref
Klaus K. Witte, Georgios Tsivgoulis, Matthew R. Reynolds, Stelios I. Tsintzos, Simon Eggington, Eleni Ismyrloglou, Julie Lyon, Marianne Huynh, Marta Egea, Bonnie de Brouwer, Paul D. Ziegler, Noreli Franco, Rashmi Joglekar, Sarah C. Rosemas, Shufeng Liu & Vincent Thijs. (2021) Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation. BMC Cardiovascular Disorders 21:1.
Crossref
Crossref
Ignacio NeumannAriel Izcovich, Ricardo AguilarGuillermo León BasantesPatricia Casais, Cecilia C. ColorioMaría Cecilia Guillermo Esposito, Pedro P. García Lázaro, Luis A. Meillon-GarcíaJaime Pereira, Suely Meireles RezendeJuan Carlos SerranoMario L. Tejerina ValleFelipe Vera, Lorena Karzulovic, Gabriel RadaHolger Schünemann. (2021) ASH, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America. Blood Advances 5:15, pages 3032-3046.
Crossref
Crossref
Ezequiel J. Zaidel, Xinyi Leng, Abiodun Moshood Adeoye, Ferdous Hakim, Biraj Karmacharya, Asim Katbeh, Lis Neubeck, Stephanie Partridge, Pablo Perel, Mark D. Huffman & Mariachiara Di Cesare. (2020) Inclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality. Global Heart 15:1.
Crossref
Crossref
Amber L Martin, Alessandra G Reeves, Samantha E Berger, Manuela Di Fusco, Gail D Wygant, Mirko Savone, Kassandra Snook, Mina Nejati & Tereza Lanitis. (2019) Systematic review of societal costs associated with stroke, bleeding and monitoring in atrial fibrillation. Journal of Comparative Effectiveness Research 8:14, pages 1147-1166.
Crossref
Crossref
Iñaki Lekuona, Manuel Anguita, José Luis Zamorano, José Manuel Rodríguez, Paloma Barja de Soroa & Ferran Pérez-Alcántara. (2019) ¿El uso de edoxabán sería coste-efectivo para la prevención del ictus y la embolia sistémica en pacientes con fibrilación auricular no valvular en España?. Revista Española de Cardiología 72:5, pages 398-406.
Crossref
Crossref
Bridget Paravattil & Hazem Elewa. (2018) Approaches to Direct Oral Anticoagulant Selection in Practice. Journal of Cardiovascular Pharmacology and Therapeutics 24:2, pages 95-102.
Crossref
Crossref
Mohammad Al Mukdad, Daoud Al-Badriyeh & Hazem Fathy Elewa. (2019) Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review. Clinical and Applied Thrombosis/Hemostasis 25, pages 107602961984910.
Crossref
Crossref
David Brieger, John Amerena, John Attia, Beata Bajorek, Kim H. Chan, Cia Connell, Ben Freedman, Caleb Ferguson, Tanya Hall, Haris Haqqani, Jeroen Hendriks, Charlotte Hespe, Joseph Hung, Jonathan M. Kalman, Prashanthan Sanders, John Worthington, Tristan D. Yan & Nicholas Zwar. (2018) National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018. Heart, Lung and Circulation 27:10, pages 1209-1266.
Crossref
Crossref
Laura Ueberham, Nikolaos Dagres, Tatjana S. Potpara, Andreas Bollmann & Gerhard Hindricks. (2017) Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation. Advances in Therapy 34:10, pages 2274-2294.
Crossref
Crossref
Andrej Janzic & Mitja Kos. (2017) Influence of novel oral anticoagulants on anticoagulation care management. Acta Pharmaceutica 67:3, pages 397-406.
Crossref
Crossref
Kathleen A. Fairman, Lindsay E. Davis, Courtney R. Kruse & David A. Sclar. (2016) Financial Impact of Direct-Acting Oral Anticoagulants in Medicaid: Budgetary Assessment Based on Number Needed to Treat. Applied Health Economics and Health Policy 15:2, pages 203-214.
Crossref
Crossref